Bay Colony Advisory Group Inc d b a Bay Colony Advisors Invests $221,000 in Agilent Technologies, Inc. (NYSE:A)

Bay Colony Advisory Group Inc d b a Bay Colony Advisors acquired a new position in shares of Agilent Technologies, Inc. (NYSE:A) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 1,589 shares of the medical research company’s stock, valued at approximately $221,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Lecap Asset Management Ltd. purchased a new stake in Agilent Technologies in the fourth quarter worth approximately $427,000. Outlook Wealth Advisors LLC purchased a new stake in Agilent Technologies in the fourth quarter worth approximately $223,000. Louisiana State Employees Retirement System purchased a new stake in Agilent Technologies in the fourth quarter worth approximately $2,461,000. MV Capital Management Inc. boosted its stake in Agilent Technologies by 120.7% in the fourth quarter. MV Capital Management Inc. now owns 192 shares of the medical research company’s stock worth $27,000 after buying an additional 105 shares in the last quarter. Finally, Horst & Graben Wealth Management LLC purchased a new stake in Agilent Technologies in the fourth quarter worth approximately $246,000.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, VP Rodney Gonsalves sold 4,828 shares of the business’s stock in a transaction dated Thursday, March 7th. The stock was sold at an average price of $149.00, for a total transaction of $719,372.00. Following the completion of the sale, the vice president now owns 21,329 shares of the company’s stock, valued at $3,178,021. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Agilent Technologies news, VP Rodney Gonsalves sold 4,828 shares of the business’s stock in a transaction dated Thursday, March 7th. The stock was sold at an average price of $149.00, for a total transaction of $719,372.00. Following the completion of the sale, the vice president now owns 21,329 shares of the company’s stock, valued at $3,178,021. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Heidi Fields sold 1,658 shares of the business’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $144.34, for a total value of $239,315.72. Following the completion of the transaction, the director now owns 54,976 shares in the company, valued at $7,935,235.84. The disclosure for this sale can be found here. Over the last quarter, insiders sold 61,610 shares of company stock valued at $9,220,333.

Analyst Ratings Changes

Several analysts have weighed in on the company. StockNews.com upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Tuesday, December 19th. Oppenheimer boosted their price objective on Agilent Technologies from $67.00 to $90.00 and gave the company an “outperform” rating in a research report on Tuesday, March 26th. UBS Group boosted their price objective on Agilent Technologies from $130.00 to $155.00 and gave the company a “neutral” rating in a research report on Wednesday, February 28th. Barclays upped their target price on Agilent Technologies from $125.00 to $135.00 and gave the company an “underweight” rating in a report on Wednesday, April 10th. Finally, Stifel Nicolaus upgraded Agilent Technologies from a “hold” rating to a “buy” rating and upped their target price for the company from $145.00 to $163.00 in a report on Friday, April 5th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $141.29.

Agilent Technologies Price Performance

Shares of A opened at $136.71 on Wednesday. The firm has a fifty day simple moving average of $141.19 and a two-hundred day simple moving average of $129.45. The firm has a market cap of $40.06 billion, a PE ratio of 32.55, a P/E/G ratio of 4.26 and a beta of 1.11. The company has a current ratio of 2.68, a quick ratio of 2.04 and a debt-to-equity ratio of 0.41. Agilent Technologies, Inc. has a 1-year low of $96.80 and a 1-year high of $151.58.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Tuesday, February 27th. The medical research company reported $1.29 EPS for the quarter, beating the consensus estimate of $1.22 by $0.07. The firm had revenue of $1.66 billion during the quarter, compared to analyst estimates of $1.59 billion. Agilent Technologies had a net margin of 18.35% and a return on equity of 27.09%. The business’s revenue for the quarter was down 5.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.37 EPS. On average, equities analysts anticipate that Agilent Technologies, Inc. will post 5.51 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 24th. Shareholders of record on Tuesday, April 2nd will be issued a dividend of $0.236 per share. This represents a $0.94 annualized dividend and a yield of 0.69%. The ex-dividend date is Monday, April 1st. Agilent Technologies’s dividend payout ratio is presently 22.38%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.